1.Department of Pediatric Oncology and Hematology, Erasmus MC, Sophia Childrens Hospital, Rotterdam, The Netherlands; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemias (DCAL), Frankfurt, Germany; AML-BFM Study Group, Hannover, Germany; Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany; m.vandenheuvel@erasmusmc.nl2.Department of Pediatric Oncology and Hematology, Erasmus MC, Sophia Children s Hospital, Rotterdam, The Netherlands; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemias (DCAL), Frankfurt, Germany; AML-BFM Study Group, Hannover, Germany; Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany; m.vandenheuvel@erasmusmc.nl
Eva A Coenen ; C Michel Zwaan ; Marry M van den Heuvel-Eibrink ; Claus Meyer ; Rolf Marschalek ; Ursula Creutzig ; Rob Pieters ; Jutta Bradtke
t(2;11)(q33;q23) KMT2A/ABI2
Atlas Genet Cytogenet Oncol Haematol. 2014-06-01
Online version: http://atlasgeneticsoncology.org/haematological/2159/t(2;11)(q33;q23)